Cargando…
Expression Profiling Identifies Bezafibrate as Potential Therapeutic Drug for Lung Adenocarcinoma
Drug-induced gene expression patterns that invert disease profiles have recently been illustrated to be a new strategy for drug-repositioning. In the present study, we validated this approach and focused on prediction of novel drugs for lung adenocarcinoma (AC), for which there is a pressing need to...
Autores principales: | Liu, Xinyan, Yang, Xiaoqin, Chen, Xinmei, Zhang, Yantao, Pan, Xuebin, Wang, Guiping, Ye, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622851/ https://www.ncbi.nlm.nih.gov/pubmed/26535062 http://dx.doi.org/10.7150/jca.12191 |
Ejemplares similares
-
Expression-Based In Silico Screening of Candidate Therapeutic Compounds for Lung Adenocarcinoma
por: Wang, Guiping, et al.
Publicado: (2011) -
Bezafibrate for X-Linked Adrenoleukodystrophy
por: Engelen, Marc, et al.
Publicado: (2012) -
Therapy of Canine Hyperlipidemia with Bezafibrate
por: De Marco, V., et al.
Publicado: (2017) -
A Mendelian randomization study for drug repurposing reveals bezafibrate and fenofibric acid as potential osteoporosis treatments
por: Li, Xiao-Hua, et al.
Publicado: (2023) -
Update on the use of fibrates: focus on bezafibrate
por: Goldenberg, Ilan, et al.
Publicado: (2008)